Brought to you by 
Prodrug R&D by Diatos and Universite Catholique de Louvin
10 Jul 2001
Executive Summary
Diatos SA (peptide delivery of drugs against cancers and infections) and the Universite Catholique de Louvain will collaborate for three years in R&D on drug delivery systems and tumor-activated prodrugs (TAPS).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
- Site Specific
-
Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com